Search our news, events & opinions

5 December 2018 0 Comments
Posted in Brexit, Events

Life after Brexit: the challenges and opportunities facing the UK’s Life Sciences sector

Author headshot image Posted by , Partner

“The life sciences industry represents one of the dominant economic sectors in the UK.
It brings significant jobs and growth to virtually every region. To retain the UK’s competitive edge in this sector, there is a requirement for sustained effort over a longer period of time”.
Professor Sir John Bell, Regius Professor of Medicine, University of Oxford and Chairman, Office for the Strategic Coordination of Health Research.

There is no doubt that the UK’s life sciences sector is exposed to Brexit. The close integration of the UK’s regulatory and research environment with the EU and the international nature of the sector means that separation is likely to be difficult and disruptive.

Meet our key speakers

However we believe that with the right strategy the sector, despite Brexit, can thrive:

  • The UK is one of the best places in the world for life sciences – there are five world-leading universities clustered around Oxford, Cambridge and London
  • It leads the way in emerging fields such as genomics and mitochondrial donation therapy
  • The Government is committed to protecting the sector and its industrial strategy has had life sciences at its centre – there is a new Life Sciences Council which brings together ministers and industry
  • Global life sciences businesses are continuing to invest in the UK – last year the UK received the highest level of life science foreign direct investment in Europe

Our event will look at the challenges facing the sector and discuss the opportunities to ensure that the UK is the best place in the world to develop and launch innovative medicines, technologies and diagnostics.

We are delighted that Professor Chas Bountra, Pro Vice Chancellor, Innovation, University of Oxford will be delivering the keynotes with Bill Haynes, MD, Site Head & Vice President, Novo Nordisk Research Centre, Oxford. There will then be a Q&A panel discussion chaired by Lord Wood of Anfield.

Event details:

Date: Thursday 28 March 2019

Time: 5.30pm – 9pm

Venue: The Ashmolean, Oxford


5.30pm    Arrival and registration

6.00pm   Welcome and introduction

6.10pm    Keynotes:

Professor Chas Bountra, Pro Vice Chancellor, Innovation, University of Oxford: Global challenges, transformative science, unique infrastructures, novel partnerships and great leaders

William Haynes, MD, Site Head & Vice President, Novo Nordisk Research Centre Oxford: Novo Nordisk Research Centre Oxford – from innovative biology to disruptive therapies

6.40pm    Q&A and panel discussion chaired by Lord Wood of Anfield

Our panellists:
Priya Mande, Chief Operating Officer, PsiOxus Therapeutics
Stephen Conway, Director of Research Services , University of Oxford
Claus Andersen, Head of Life Sciences, Royds Withy King
Thomas Bjorn, Life Sciences Consultant, Royds Withy King

7.25pm    Closing comments

7.35pm    Drinks and networking

9.00pm    Finish

For further information or to book your place, please contact us on:     Email us0800 151 2043

Leave a comment

Thank you for choosing to leave a comment. Please keep in mind that comments are moderated and please do not use a spammy keyword or a domain as your name or it will be deleted.




Search our news, events & opinions